JPS59196818A - 腎炎治療剤 - Google Patents
腎炎治療剤Info
- Publication number
- JPS59196818A JPS59196818A JP7243683A JP7243683A JPS59196818A JP S59196818 A JPS59196818 A JP S59196818A JP 7243683 A JP7243683 A JP 7243683A JP 7243683 A JP7243683 A JP 7243683A JP S59196818 A JPS59196818 A JP S59196818A
- Authority
- JP
- Japan
- Prior art keywords
- nephritis
- formula
- remedy
- present
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000008383 nephritis Diseases 0.000 title abstract description 9
- 239000004480 active ingredient Substances 0.000 claims description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- HUMNYLRZRPPJDN-KWCOIAHCSA-N benzaldehyde Chemical group O=[11CH]C1=CC=CC=C1 HUMNYLRZRPPJDN-KWCOIAHCSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 8
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 7
- 206010018364 Glomerulonephritis Diseases 0.000 abstract description 6
- 150000003935 benzaldehydes Chemical class 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 230000002062 proliferating effect Effects 0.000 abstract description 3
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 239000003937 drug carrier Substances 0.000 abstract description 2
- 231100000053 low toxicity Toxicity 0.000 abstract description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 abstract 2
- 239000000470 constituent Substances 0.000 abstract 2
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 239000003086 colorant Substances 0.000 abstract 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 17
- 230000001629 suppression Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- RGZHEOWNTDJLAQ-UHFFFAOYSA-N 3,4,5-trihydroxybenzaldehyde Chemical compound OC1=CC(C=O)=CC(O)=C1O RGZHEOWNTDJLAQ-UHFFFAOYSA-N 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 201000008171 proliferative glomerulonephritis Diseases 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- BTQAJGSMXCDDAJ-UHFFFAOYSA-N 2,4,6-trihydroxybenzaldehyde Chemical compound OC1=CC(O)=C(C=O)C(O)=C1 BTQAJGSMXCDDAJ-UHFFFAOYSA-N 0.000 description 2
- CLFRCXCBWIQVRN-UHFFFAOYSA-N 2,5-dihydroxybenzaldehyde Chemical compound OC1=CC=C(O)C(C=O)=C1 CLFRCXCBWIQVRN-UHFFFAOYSA-N 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 201000001474 proteinuria Diseases 0.000 description 2
- 231100001028 renal lesion Toxicity 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- -1 ampoules Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000001290 inhibitory effect on nephritis Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7243683A JPS59196818A (ja) | 1983-04-25 | 1983-04-25 | 腎炎治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7243683A JPS59196818A (ja) | 1983-04-25 | 1983-04-25 | 腎炎治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59196818A true JPS59196818A (ja) | 1984-11-08 |
| JPH0435444B2 JPH0435444B2 (enrdf_load_stackoverflow) | 1992-06-11 |
Family
ID=13489246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7243683A Granted JPS59196818A (ja) | 1983-04-25 | 1983-04-25 | 腎炎治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59196818A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4997850A (en) * | 1989-04-28 | 1991-03-05 | Kureha Kagaku Kogyo Kabushiki Kaisha | Treating agent for osteroarthritis |
-
1983
- 1983-04-25 JP JP7243683A patent/JPS59196818A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4997850A (en) * | 1989-04-28 | 1991-03-05 | Kureha Kagaku Kogyo Kabushiki Kaisha | Treating agent for osteroarthritis |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0435444B2 (enrdf_load_stackoverflow) | 1992-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK282403B6 (sk) | 2,4-Disulfonyl-alfa-fenyl-terc-butylnitrón alebo jeho farmaceuticky prijateľná soľ, farmaceutický prostriedok s ich obsahom a ich použitie | |
| JPS62215527A (ja) | アルツハイマー病治療薬 | |
| JPS62249923A (ja) | パ−キンソン病、うつ病、ナルコレプシ−および脳器官精神症候群の抑制用薬剤およびその製造方法 | |
| TWI564291B (zh) | 一氧化氮生成調節劑 | |
| JPS61151123A (ja) | 安定化された３―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤 | |
| JP2019523260A (ja) | キラルペプチド | |
| JPS61129129A (ja) | 抗腫瘍剤 | |
| WO2011111070A2 (en) | Novel injectable combination | |
| JP2025011312A (ja) | ｐ－ボロノフェニルアラニンを含有する注射液剤の析出防止方法 | |
| EP1963270B1 (en) | Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents | |
| JP7514841B2 (ja) | ４－アルキル－５－ヘテロアリール－３ｈ－１，２－ジチオール－３－チオンの回転異性体 | |
| JPS59196818A (ja) | 腎炎治療剤 | |
| JPS5938207B2 (ja) | 腎疾患治療剤 | |
| JP7498475B2 (ja) | 多発性骨髄腫の治療剤 | |
| WO2023016495A1 (zh) | 含有白果内酯和大麻二酚的药物组合物及其在医药上的应用 | |
| JPH0515694B2 (enrdf_load_stackoverflow) | ||
| US3856971A (en) | Method of combating filariasis in dogs | |
| US3222253A (en) | Antimitotic colchicines | |
| JPH10175876A (ja) | 鉄キレート化用製剤、その製剤の製法及び地中海貧血症の治療法 | |
| RU2676279C1 (ru) | Стабильное противоопухолевое лекарственное средство, способ его получения и применения | |
| JPS61129124A (ja) | 抗腫瘍剤 | |
| JPS63225381A (ja) | 肝疾患治療剤 | |
| JPH03287531A (ja) | 膵炎治療薬 | |
| JPS5973522A (ja) | 脳神経細胞の酸素欠乏性疾患治療剤 | |
| JPH01156916A (ja) | 肝疾患治療剤 |